Skip to content
777 Sourcing.

Capability

inhalation drug development

Suppliers
1
States & provinces
1
Countries
1

1 inhalation drug development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

DANMIR THERAPEUTICS LLC

NEWTOWN SQUARE, PA

Danmir Therapeutics, LLC is an emerging biopharmaceutical company focusing on novel therapeutic approaches based on pharmacologic manipulation of P2 receptors' signal transductions activated by extracellular adenosine 5'-triphosphate (ATP). Its lead drug candidate DT-0111 (Aspirex) is a water-soluble selective P2X2/3 receptor antagonist in development as an inhalation drug for COPD and chronic cough. The company was founded in 2008 by Amir Pelleg, Ph.D.

drug developmentoral drug formulationpharmacologic manipulation of P2 receptor signal transductions

Compiled from public sources

Related capabilities

Other processes offered by the shops that list inhalation drug development.

Browse all capabilities